“Pharmacogenetic effects of angiotensin-converting enzyme inhibitors over age-related urea and creatinine variations in patients with dementia due to Alzheimer disease” (2016) Colombia Medica, 47(2), pp. 76–80. doi:10.25100/cm.v47i2.2188.